Table 2 Surgical management and postoperative outcome

1.

Baseline BCVA at presentation

2.69 ± 0.57 (<20/2000)

2.

BCVA at 1 months postoperative visit improvement from baseline

1.65 (SD 0.93, 20/800, p = 0.001), range 20/20 to no PL, 0.99 logMAR units, (p = < 0.001, 95 % CI 0.64–1.34)

3.

BCVA at 6 months postoperative visit

1.53 (SD 1.2, 20/600, p = 0.0001), range 20/20 to no PL

4.

Improvement from baseline to last visit

0.96 logMAR units, (p < 0.0001, 95 % CI 0.54–1.37)

5.

Mean follow up

14.8 months (range 1–84 months)

6.

BCVA improved by two lines or more than presenting VA at last follow up

16 of 28 eyes (57.1 %)

7.

BCVA worsened at last follow up than baseline BCVA

3 of 28 eyes (10.7 %)

8.

Complications

Cataract (n = 10), macular scar (n = 4), organised dehemoglobinised blood/exudates (n = 7), retinal detachment (n = 5), iatrogenic retinal breaks (n = 5), recurrent VH (n = 3), choroidal detachment (n = 1)